$10.070
+0.309 (+3.07%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
XERS Prediction & Forecast by Similar Chart Analysis
Alphio's XERS stock price prediction model matches the current Xeris Biopharma Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.88 (-1.91%). The 1-week path is $9.91 (-1.54%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Xeris Biopharma Holdings Inc Stock?
Xeris Biopharma Holdings Inc is a good buy right now due to its strong revenue growth and promising product pipeline. The current price is $10.48, and the company reported a 29% year-over-year increase in Q2 revenue to $92.1 million, driven by a significant rise in Recorlev sales. Additionally, the RSI is at 76.93, indicating strong momentum. However, the main risk is the net loss of $31.1 million reported in Q2 2026, which highlights ongoing financial challenges.
XERS stock price ended at $10.07 on Thursday, after rising +3.07%
Xeris Biopharma Holdings Inc (XERS) last closed at $10.07, gaining +3.07%. These facts feed the 1-day and 1-week XERS price prediction above.
Analyst Consensus
Xeris Biopharma Holdings Inc (XERS): 4 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Xeris Biopharma Holdings Inc (XERS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches XERS, ranked by similarity.
Seasonality analysis for XERS
Historically the probability of a positive October return for XERS is 100.00%. September offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for XERS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $5.45 | $6.45 | $6.50 | -35.95% |
| Nov 2026 | $5.01 | $5.27 | $5.34 | -47.66% |
| Dec 2026 | $5.31 | $5.94 | $6.84 | -41.04% |
In 2026, Xeris Biopharma Holdings Inc (XERS) is projected to range from $5.01 to $6.84.
Xeris Biopharma Holdings Inc 2026 monthly forecast
In Oct 2026, Xeris Biopharma Holdings Inc is projected to average $6.45, with a low of $5.45 and high of $6.50.
In Nov 2026, Xeris Biopharma Holdings Inc is projected to average $5.27, with a low of $5.01 and high of $5.34.
In Dec 2026, Xeris Biopharma Holdings Inc is projected to average $5.94, with a low of $5.31 and high of $6.84.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.